Table III.

Associations between the expression of integrin β1A, hnRNP E1 and the categorical clinicopathological parameters of pancreatic carcinoma.

Parameters	Integrin β1A mRNA expression		Cytoplasmic hnRNP E1 protein expression
	Median expression (range)	P-value	Low	High	P-value
Age (years)		0.183			0.805
<65	44.343 (24.355–82.093)		27	29
≥65	28.273 (17.489–58.197)		9	11
Sex		0.847			0.092
Male	37.853 (18.741–74.376)		5	12
Female	28.671 (23.728–79.674)		31	28
Tumor size (cm)		0.517			0.961
≤2	55.170 (23.557–80.806)		16	18
>2	29.847 (18.257–74.357)		20	22
Tumor location		0.601			0.108
Head	35.482 (21.230–74.376)		34	33
Body and tail	64.364 (27.496–79.674)		2	7
Lymph node metastasis		0.001			0.004
Negative	28.051 (10.770–57.022)		27	17
Positive	70.630 (34.876–96.331)		9	23
Vascular invasion		0.150			0.258
Negative	36.222 (25.467–77.838)		30	29
Positive	29.816 (5.563–64.032)		6	11
Neural invasion		0.147			0.426
Negative	29.361 (9.563–56.324)		11	9
Positive	40.934 (25.618–80.162)		25	31
Duodenal invasion		0.328			0.417
Negative	27.934 (9.758–63.527)		8	6
Positive	37.038 (24.087–78.756)		28	34
Hepatic metastases		0.005			0.011
Negative	29.847 (16.785–69.192)		35	31
Positive	72.487 (64.115–106.964)		1	9
Differentiation		0.56			0.404
Well	49.798 (25.015–69.084)		1	4
Moderate	35.482 (18.741–80.892)		26	25
Poor	28.189 (25.769–30.836)		9	11
T-stage (UICC)		0.419			0.077
T1, 2	35.482 (25.467–77.188)		26	21
T3, 4	39.998 (12.114–76.003)		10	19
Tumor stage (UICC)		0.002			0.001
I	28.632 (13.919–44.015)		21	8
II	46.717 (18.839–82.530)		14	22
III, IV	76.003 (54.517–117.941)		1	10

The bold values indicate P-values <0.05, UICC Union for International Cancer Control.